UCSF team uncovers breakthrough immunotherapy for colon cancer liver metastases
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest…
Supplements that aren’t a magic fix, but you are taking them anyway
The supplement sales have surpassed $150 billion in the United States in 2023. There are over 80,000 unique…
Harnessing “DNA surgery” to develop therapeutic medicines for genetic liver and heart diseases
Genome editing is increasingly recognzed as a leading frontier in biomedical research and an essential driver of healthcare…
Study shows prediabetes remission does not always require weight loss
New evidence shows that restoring normal glucose regulation can shield against diabetes even without weight loss, reshaping prevention…
Molecular fingerprint predicts physical fitness in older adults
Could a simple blood test reveal how well someone is aging? A team of researchers led by Wolfram…
Plant-Based vs. red meat impact
New research reveals just how much greener plant-based kibble is compared to meat-based dog food, from saving football…
Precision probiotics lower blood sugar and cholesterol in mice
A new mouse study reveals that carefully selected probiotics can lower blood sugar, body fat, and cholesterol levels…
Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
Intravenous lactate raises pro-BDNF levels similar to high intensity workouts
Science has confirmed what sports lovers have always known from experience: exercise is good for the brain. It…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Researchers reveal why global gains against chronic diseases are stalling
Despite overall declines in premature non-communicable disease deaths, the study reveals faltering progress driven by uneven regional trends…
Scientists Unveil Potential First-of-Its-Kind Treatment for Deadly Fatty Liver Disease
Scientists at UC San Diego have tested a new drug that directly targets fat production in the liver,…